Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-25-019219
Filing Date
2025-07-15
Accepted
2025-07-15 17:17:29
Documents
2
Period of Report
2025-07-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 1420
2 POWER OF ATTORNEY (PUBLIC): POA doc1.txt EX-24 3412
  Complete submission text file 0001127602-25-019219.txt   6584
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Issuer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 160 SOUTH INDUSTRIAL BLVD CALHOUN GA 30701
Business Address
LEE STEVEN HYOSIG (Reporting) CIK: 0001855708 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-14956 | Film No.: 251125643